<i>CYB5R4</i> Gene Methylation as a Potential Epigenetic Marker for Ovarian Cancer
The <i>CYB5R4</i> gene methylation may serve as a potential biomarker for ovarian cancer, particularly in distinguishing between malignant and benign conditions. Further research is needed to validate these findings and explore the clinical utility of <i>CYB5R4</i> methylation in ovarian cancer management.
Authors
- Özge Pasin (ORCID: https://orcid.org/0000-0001-6530-0942)
- Hülya Yazıcı (ORCID: https://orcid.org/0000-0002-8919-0482)
- Betül Çelik (ORCID: https://orcid.org/0000-0001-7923-275X)
- Pınar Mualla Saip (ORCID: https://orcid.org/0000-0001-6871-8519)
- Özge Şükrüoğlu Erdoğan (ORCID: https://orcid.org/0000-0002-0893-1251)
- Şeref Buğra Tunçer (ORCID: https://orcid.org/0000-0001-8023-3223)
- Seda Kılıç (ORCID: https://orcid.org/0000-0003-4417-4005)
- Aysegul Gonc
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Cancer Genetics (United States) (US)
- Istanbul University (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1177/11795549251340531
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00